Overall Status

Completed (172)

Recruiting (51)

Terminated (35)

Not yet recruiting (24)

Unknown status (18)

Active, not recruiting (13)

Withdrawn (12)

Enrolling by invitation (2)

Available (1)

Phase

phase 2 (107)

phase 1 (55)

phase 3 (40)

phase 1/phase 2 (28)

n/a (21)

phase 4 (8)

phase 2/phase 3 (3)

early phase 1 (2)

Study Documents

Funder Type

Other (187)

Industry (126)

NIH (15)

Study Type

Interventional (264)

Observational (56)

Observational [Patient Registry] (7)

Expanded Access (1)

Thrombocythemia

Showing 326 - 328 of 328

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Tucson (mAb A27.15, mAb E2.3)

Completed

Chronic Myeloproliferative Disorders
+6 more

monoclonal antibody A27.15
monoclonal antibody E2.3

Tucson, Arizona

Arizona Cancer Center

Mar 12, 2010

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New Brunswick (tetradecanoylphorbol acetate)

Terminated

Chronic Myeloproliferative Disorders
+6 more

tetradecanoylphorbol acetate

New Brunswick, New Jersey

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me

Jan 25, 2010

Bone Marrow Transplant Chart Review for RIC

Completed

Myelofibrosis

Reduced Intensity Conditioning (RIC) Allogenic Transplant

Houston, Texas
+3 more

Oct 8, 2009